| 2.8 |
8.3 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 2.0 |
6.0 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 2.0 |
12.0 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 1.9 |
5.8 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 1.9 |
5.6 |
GO:0010881 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 1.9 |
5.6 |
GO:0051088 |
PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.7 |
6.9 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 1.6 |
4.7 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 1.5 |
7.3 |
GO:0044854 |
membrane raft assembly(GO:0001765) plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) membrane assembly(GO:0071709) |
| 1.4 |
5.7 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 1.4 |
11.3 |
GO:0003065 |
regulation of heart rate by chemical signal(GO:0003062) positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.4 |
5.6 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 1.3 |
1.3 |
GO:0055098 |
response to low-density lipoprotein particle(GO:0055098) |
| 1.3 |
7.6 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 1.2 |
1.2 |
GO:0060192 |
negative regulation of lipoprotein lipase activity(GO:0051005) negative regulation of lipase activity(GO:0060192) |
| 1.2 |
4.7 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 1.2 |
3.5 |
GO:0010837 |
regulation of keratinocyte proliferation(GO:0010837) |
| 1.1 |
3.4 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.1 |
3.4 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 1.1 |
4.3 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.1 |
3.2 |
GO:0048627 |
myoblast development(GO:0048627) |
| 1.0 |
6.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 1.0 |
2.0 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 1.0 |
4.0 |
GO:2000008 |
regulation of protein localization to cell surface(GO:2000008) |
| 1.0 |
3.0 |
GO:0070092 |
regulation of glucagon secretion(GO:0070092) |
| 1.0 |
2.9 |
GO:2000064 |
regulation of cortisol biosynthetic process(GO:2000064) |
| 1.0 |
1.9 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.0 |
5.8 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.0 |
4.8 |
GO:1903960 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
| 1.0 |
3.8 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.9 |
4.7 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.9 |
0.9 |
GO:0035987 |
endodermal cell fate commitment(GO:0001711) endodermal cell differentiation(GO:0035987) |
| 0.9 |
2.7 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.9 |
2.7 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.9 |
2.6 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.9 |
5.2 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.9 |
2.6 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.8 |
2.5 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.8 |
2.5 |
GO:0034036 |
purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.8 |
1.6 |
GO:0090047 |
obsolete positive regulation of transcription regulator activity(GO:0090047) |
| 0.8 |
2.5 |
GO:0060831 |
smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
| 0.8 |
2.5 |
GO:1902803 |
regulation of synaptic vesicle transport(GO:1902803) regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.8 |
2.4 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.8 |
3.1 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.8 |
22.4 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.8 |
3.1 |
GO:0006927 |
obsolete transformed cell apoptotic process(GO:0006927) |
| 0.8 |
6.2 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.8 |
5.4 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.8 |
2.3 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
| 0.8 |
7.6 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.7 |
0.7 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.7 |
2.2 |
GO:0002575 |
basophil chemotaxis(GO:0002575) |
| 0.7 |
11.0 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.7 |
0.7 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.7 |
3.5 |
GO:0010561 |
negative regulation of glycoprotein biosynthetic process(GO:0010561) |
| 0.7 |
2.1 |
GO:0021823 |
cerebral cortex tangential migration using cell-cell interactions(GO:0021823) substrate-dependent cerebral cortex tangential migration(GO:0021825) postnatal olfactory bulb interneuron migration(GO:0021827) |
| 0.7 |
4.1 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 |
1.3 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.7 |
9.3 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.6 |
0.6 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.6 |
1.3 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.6 |
3.8 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.6 |
0.6 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.6 |
3.0 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.6 |
5.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.6 |
1.2 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.6 |
2.4 |
GO:2001258 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) negative regulation of calcium ion transmembrane transporter activity(GO:1901020) negative regulation of cation channel activity(GO:2001258) |
| 0.6 |
2.4 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.6 |
1.8 |
GO:2000121 |
regulation of removal of superoxide radicals(GO:2000121) |
| 0.6 |
1.8 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 |
0.6 |
GO:0010882 |
regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
| 0.6 |
1.7 |
GO:0071476 |
response to vitamin B1(GO:0010266) cellular hypotonic response(GO:0071476) |
| 0.6 |
1.7 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.6 |
2.8 |
GO:0019471 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
| 0.6 |
10.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.6 |
2.8 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.6 |
1.7 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.6 |
2.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.6 |
3.3 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.6 |
1.7 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.6 |
3.9 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.5 |
1.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.5 |
4.9 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.5 |
1.6 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.5 |
1.6 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.5 |
0.5 |
GO:0014044 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.5 |
2.1 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.5 |
3.6 |
GO:0034465 |
cellular potassium ion homeostasis(GO:0030007) response to carbon monoxide(GO:0034465) negative regulation of cell volume(GO:0045794) |
| 0.5 |
0.5 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.5 |
1.5 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.5 |
4.0 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.5 |
1.5 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.5 |
3.4 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
| 0.5 |
1.9 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.5 |
1.5 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.5 |
1.9 |
GO:0060209 |
estrus(GO:0060209) |
| 0.5 |
4.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.5 |
2.4 |
GO:0071772 |
BMP signaling pathway(GO:0030509) response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
| 0.5 |
0.9 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.5 |
6.1 |
GO:0034446 |
substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.5 |
2.8 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.5 |
0.5 |
GO:0097709 |
connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
| 0.5 |
1.4 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.5 |
1.4 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.5 |
0.9 |
GO:0035120 |
post-embryonic appendage morphogenesis(GO:0035120) |
| 0.5 |
0.5 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.5 |
2.3 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
| 0.4 |
2.7 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.4 |
1.8 |
GO:0071071 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) regulation of phospholipid biosynthetic process(GO:0071071) |
| 0.4 |
1.3 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.4 |
1.8 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.4 |
2.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.4 |
1.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.4 |
3.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.4 |
1.3 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.4 |
3.9 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.4 |
1.3 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.4 |
2.6 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.4 |
0.4 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.4 |
1.3 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.4 |
1.7 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.4 |
7.0 |
GO:0050812 |
acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.4 |
2.5 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.4 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.4 |
1.6 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.4 |
2.0 |
GO:0097531 |
mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
| 0.4 |
3.7 |
GO:0032528 |
microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.4 |
2.8 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.4 |
1.2 |
GO:0006740 |
NADPH regeneration(GO:0006740) |
| 0.4 |
0.4 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.4 |
1.6 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 0.4 |
2.0 |
GO:0060347 |
heart trabecula formation(GO:0060347) heart trabecula morphogenesis(GO:0061384) |
| 0.4 |
0.8 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.4 |
0.4 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
| 0.4 |
1.9 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of cell junction assembly(GO:1901890) positive regulation of adherens junction organization(GO:1903393) |
| 0.4 |
0.8 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.4 |
0.4 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.4 |
1.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.4 |
0.8 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.4 |
1.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.4 |
1.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.4 |
0.7 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) demethylation(GO:0070988) |
| 0.4 |
1.5 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.4 |
2.2 |
GO:0090025 |
regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.4 |
0.4 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.4 |
2.2 |
GO:0032429 |
regulation of phospholipase A2 activity(GO:0032429) |
| 0.4 |
1.1 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 |
1.5 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.4 |
3.6 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.4 |
3.6 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.4 |
1.4 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 |
1.1 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.4 |
4.3 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.4 |
3.9 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.4 |
3.2 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.4 |
1.4 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.3 |
0.3 |
GO:0048771 |
tissue remodeling(GO:0048771) |
| 0.3 |
1.7 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.3 |
0.7 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.3 |
1.0 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
| 0.3 |
2.1 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.3 |
1.7 |
GO:1903008 |
organelle disassembly(GO:1903008) |
| 0.3 |
1.7 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.3 |
0.7 |
GO:0070884 |
calcineurin-NFAT signaling cascade(GO:0033173) regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.3 |
33.8 |
GO:0008154 |
actin polymerization or depolymerization(GO:0008154) |
| 0.3 |
22.7 |
GO:0034332 |
adherens junction organization(GO:0034332) |
| 0.3 |
2.0 |
GO:0007500 |
mesodermal cell fate determination(GO:0007500) |
| 0.3 |
3.3 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.3 |
6.5 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.3 |
1.0 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.3 |
1.0 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.3 |
1.9 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 0.3 |
0.9 |
GO:0031133 |
regulation of axon diameter(GO:0031133) regulation of cell projection size(GO:0032536) |
| 0.3 |
5.0 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.3 |
1.3 |
GO:0030240 |
skeletal myofibril assembly(GO:0014866) skeletal muscle thin filament assembly(GO:0030240) |
| 0.3 |
3.1 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.3 |
0.3 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.3 |
1.9 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.3 |
2.5 |
GO:0002011 |
morphogenesis of an epithelial sheet(GO:0002011) |
| 0.3 |
0.9 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.3 |
0.9 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.3 |
0.3 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.3 |
0.9 |
GO:0050758 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 |
1.2 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.3 |
0.9 |
GO:0060129 |
corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 0.3 |
0.3 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
0.3 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.3 |
0.6 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.3 |
1.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.3 |
0.3 |
GO:0050968 |
detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.3 |
2.0 |
GO:0060414 |
aorta development(GO:0035904) aorta morphogenesis(GO:0035909) aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.3 |
0.3 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.3 |
0.6 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.3 |
0.6 |
GO:0021570 |
rhombomere 4 development(GO:0021570) |
| 0.3 |
1.7 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.3 |
3.8 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.3 |
1.4 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
1.1 |
GO:0002331 |
immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.3 |
0.8 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.3 |
0.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.3 |
1.8 |
GO:0015904 |
tetracycline transport(GO:0015904) |
| 0.3 |
0.8 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.3 |
0.3 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.3 |
1.0 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.3 |
3.8 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 |
2.3 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.3 |
0.8 |
GO:0034244 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 |
0.5 |
GO:0071479 |
cellular response to radiation(GO:0071478) cellular response to ionizing radiation(GO:0071479) |
| 0.2 |
0.7 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.2 |
0.7 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.2 |
0.7 |
GO:0016476 |
regulation of embryonic cell shape(GO:0016476) |
| 0.2 |
3.6 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.2 |
1.2 |
GO:0050932 |
regulation of melanocyte differentiation(GO:0045634) regulation of pigment cell differentiation(GO:0050932) |
| 0.2 |
0.5 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
| 0.2 |
1.4 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
0.7 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.2 |
1.6 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.2 |
1.6 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.2 |
5.7 |
GO:0043462 |
regulation of ATPase activity(GO:0043462) |
| 0.2 |
0.7 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) glycerophospholipid catabolic process(GO:0046475) |
| 0.2 |
0.4 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.2 |
2.0 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.2 |
3.6 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.2 |
0.4 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.2 |
0.7 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 |
0.2 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.2 |
1.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 |
1.3 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.2 |
5.2 |
GO:0048010 |
vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.2 |
1.1 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.2 |
1.1 |
GO:1903020 |
positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.2 |
0.2 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
1.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 |
1.3 |
GO:0048488 |
synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
| 0.2 |
0.6 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.2 |
0.8 |
GO:0015825 |
L-serine transport(GO:0015825) |
| 0.2 |
1.5 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.2 |
1.9 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.2 |
2.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.2 |
1.2 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.2 |
0.6 |
GO:0042159 |
lipoprotein catabolic process(GO:0042159) |
| 0.2 |
0.8 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.2 |
0.8 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 |
1.4 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.2 |
1.4 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.2 |
0.6 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.2 |
0.2 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.2 |
1.2 |
GO:0045916 |
negative regulation of protein processing(GO:0010955) negative regulation of complement activation(GO:0045916) negative regulation of protein maturation(GO:1903318) negative regulation of protein activation cascade(GO:2000258) |
| 0.2 |
0.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.2 |
0.6 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.2 |
3.0 |
GO:0000768 |
syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
| 0.2 |
3.9 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
| 0.2 |
0.2 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.2 |
0.6 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) |
| 0.2 |
1.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.2 |
1.3 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.2 |
2.8 |
GO:0098764 |
meiosis I cell cycle phase(GO:0098764) |
| 0.2 |
0.4 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.2 |
0.4 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.2 |
0.9 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.2 |
0.9 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.2 |
0.4 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 |
1.1 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 0.2 |
0.5 |
GO:0050685 |
positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
| 0.2 |
0.4 |
GO:0016241 |
regulation of macroautophagy(GO:0016241) |
| 0.2 |
0.2 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.2 |
0.9 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
0.5 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.2 |
1.4 |
GO:0010812 |
negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.2 |
0.2 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.2 |
1.4 |
GO:0042516 |
regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
| 0.2 |
0.4 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 |
0.5 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.2 |
0.7 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.2 |
0.7 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
0.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
0.8 |
GO:0021548 |
pons development(GO:0021548) |
| 0.2 |
2.5 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.2 |
0.5 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.2 |
0.3 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
1.2 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.2 |
0.2 |
GO:0045926 |
negative regulation of growth(GO:0045926) |
| 0.2 |
0.7 |
GO:0033688 |
regulation of osteoblast proliferation(GO:0033688) |
| 0.2 |
1.8 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.7 |
GO:0042693 |
muscle cell fate commitment(GO:0042693) |
| 0.2 |
0.5 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 |
1.0 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.2 |
0.6 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.2 |
1.3 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 |
0.2 |
GO:0060343 |
trabecula formation(GO:0060343) trabecula morphogenesis(GO:0061383) |
| 0.2 |
0.8 |
GO:0051927 |
obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
| 0.2 |
0.5 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.2 |
1.7 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.2 |
0.6 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.2 |
2.5 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 0.2 |
2.5 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 |
1.1 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.2 |
0.5 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.2 |
0.5 |
GO:0045062 |
extrathymic T cell differentiation(GO:0033078) extrathymic T cell selection(GO:0045062) |
| 0.2 |
0.3 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.2 |
3.1 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.2 |
0.6 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.2 |
0.5 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.2 |
0.3 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.2 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
0.3 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 |
0.6 |
GO:0048261 |
negative regulation of receptor-mediated endocytosis(GO:0048261) |
| 0.2 |
1.8 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.2 |
3.2 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.2 |
1.7 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.2 |
0.9 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.6 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide metabolic process(GO:0006678) glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.4 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.1 |
0.7 |
GO:0015827 |
tryptophan transport(GO:0015827) leucine import(GO:0060356) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.3 |
GO:0060405 |
regulation of penile erection(GO:0060405) |
| 0.1 |
0.9 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
2.7 |
GO:0016236 |
macroautophagy(GO:0016236) |
| 0.1 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.3 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.1 |
0.3 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 0.1 |
27.8 |
GO:0007517 |
muscle organ development(GO:0007517) |
| 0.1 |
0.4 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.9 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.1 |
0.7 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.4 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 |
0.1 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.6 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.1 |
1.8 |
GO:0050654 |
chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
| 0.1 |
1.0 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.1 |
1.2 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 |
1.4 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.4 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.7 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
1.3 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.7 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.4 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.6 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.6 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.5 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.4 |
GO:0018243 |
protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
1.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.8 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.1 |
3.4 |
GO:0032963 |
collagen metabolic process(GO:0032963) |
| 0.1 |
0.8 |
GO:0045542 |
positive regulation of cholesterol biosynthetic process(GO:0045542) |
| 0.1 |
0.9 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.5 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.1 |
GO:0097435 |
extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
| 0.1 |
3.8 |
GO:0007613 |
memory(GO:0007613) |
| 0.1 |
2.0 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
| 0.1 |
3.5 |
GO:0006693 |
prostaglandin metabolic process(GO:0006693) |
| 0.1 |
0.1 |
GO:0043270 |
positive regulation of ion transport(GO:0043270) |
| 0.1 |
2.3 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 |
0.7 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
2.4 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.1 |
3.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
8.5 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.1 |
0.2 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.1 |
0.8 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.2 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
0.6 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.1 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
9.8 |
GO:0002576 |
platelet degranulation(GO:0002576) |
| 0.1 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
1.5 |
GO:1901224 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.1 |
0.8 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0034341 |
response to interferon-gamma(GO:0034341) |
| 0.1 |
0.7 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.1 |
0.6 |
GO:0032909 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.1 |
0.6 |
GO:0031946 |
regulation of glucocorticoid biosynthetic process(GO:0031946) |
| 0.1 |
1.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.1 |
0.2 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.1 |
0.1 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.1 |
0.4 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 |
2.6 |
GO:0007033 |
vacuole organization(GO:0007033) |
| 0.1 |
0.2 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 0.1 |
1.4 |
GO:0097031 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.1 |
GO:0051957 |
positive regulation of amino acid transport(GO:0051957) |
| 0.1 |
0.1 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
1.4 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.9 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.2 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 |
0.9 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.1 |
0.3 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
0.9 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.1 |
0.7 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.1 |
3.9 |
GO:0007043 |
cell-cell junction assembly(GO:0007043) |
| 0.1 |
0.4 |
GO:0006694 |
steroid biosynthetic process(GO:0006694) |
| 0.1 |
0.3 |
GO:0021924 |
cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 |
0.4 |
GO:0032922 |
circadian regulation of gene expression(GO:0032922) |
| 0.1 |
0.8 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.1 |
0.2 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
3.7 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
0.3 |
GO:1902414 |
positive regulation of receptor recycling(GO:0001921) protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.1 |
0.1 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 |
0.4 |
GO:0017014 |
protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
| 0.1 |
2.3 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.1 |
0.2 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.1 |
0.3 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 |
0.4 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.7 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.1 |
0.4 |
GO:0071260 |
cellular response to abiotic stimulus(GO:0071214) cellular response to mechanical stimulus(GO:0071260) |
| 0.1 |
0.6 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting two-sector ATPase complex assembly(GO:0070071) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
2.3 |
GO:0051899 |
membrane depolarization(GO:0051899) |
| 0.1 |
0.5 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 |
1.2 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 |
0.7 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.1 |
0.3 |
GO:0034626 |
fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.3 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.1 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
1.6 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.1 |
0.2 |
GO:0008356 |
asymmetric cell division(GO:0008356) |
| 0.1 |
0.9 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.1 |
1.1 |
GO:0006024 |
glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.1 |
1.3 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.1 |
2.1 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.1 |
2.8 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
| 0.1 |
0.2 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 |
0.4 |
GO:1903301 |
regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.6 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.1 |
0.6 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.1 |
0.6 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.1 |
0.6 |
GO:0021955 |
central nervous system projection neuron axonogenesis(GO:0021952) central nervous system neuron axonogenesis(GO:0021955) |
| 0.1 |
0.6 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.9 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
| 0.1 |
0.2 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
1.3 |
GO:0003407 |
neural retina development(GO:0003407) |
| 0.1 |
0.2 |
GO:0071901 |
negative regulation of protein serine/threonine kinase activity(GO:0071901) |
| 0.1 |
0.2 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.1 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.3 |
GO:0009109 |
coenzyme catabolic process(GO:0009109) |
| 0.1 |
0.9 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
0.6 |
GO:0044273 |
sulfur compound catabolic process(GO:0044273) |
| 0.1 |
0.1 |
GO:0048562 |
embryonic organ morphogenesis(GO:0048562) |
| 0.1 |
0.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 |
0.1 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.1 |
0.4 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
3.2 |
GO:0030198 |
extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.1 |
0.8 |
GO:1901797 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
| 0.1 |
1.9 |
GO:0046324 |
regulation of glucose import(GO:0046324) |
| 0.1 |
0.4 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
2.2 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.1 |
0.2 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
2.5 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 |
0.7 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
| 0.1 |
3.6 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.1 |
0.9 |
GO:0010952 |
positive regulation of peptidase activity(GO:0010952) |
| 0.1 |
20.5 |
GO:0097485 |
axon guidance(GO:0007411) neuron projection guidance(GO:0097485) |
| 0.1 |
0.1 |
GO:0060073 |
micturition(GO:0060073) |
| 0.1 |
0.4 |
GO:0000090 |
mitotic anaphase(GO:0000090) |
| 0.1 |
0.7 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.1 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.1 |
0.2 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.1 |
1.2 |
GO:0007498 |
mesoderm development(GO:0007498) |
| 0.1 |
0.1 |
GO:0060972 |
left/right pattern formation(GO:0060972) |
| 0.1 |
0.2 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.1 |
0.3 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.1 |
GO:0032367 |
intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.1 |
0.1 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
0.4 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.1 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) striated muscle adaptation(GO:0014888) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.5 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.4 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.1 |
0.6 |
GO:0001709 |
cell fate determination(GO:0001709) |
| 0.1 |
0.6 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.8 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.2 |
GO:0010766 |
negative regulation of sodium ion transport(GO:0010766) |
| 0.1 |
0.6 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.5 |
GO:0007628 |
adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
| 0.1 |
0.2 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 0.1 |
0.3 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.2 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
2.3 |
GO:0019432 |
triglyceride biosynthetic process(GO:0019432) |
| 0.1 |
1.5 |
GO:0034329 |
cell junction assembly(GO:0034329) |
| 0.1 |
0.6 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 |
0.1 |
GO:0032106 |
positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.1 |
0.8 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.9 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.2 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.4 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 |
0.3 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.1 |
0.3 |
GO:0006029 |
proteoglycan metabolic process(GO:0006029) |
| 0.1 |
0.2 |
GO:0006530 |
asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.1 |
0.3 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.1 |
0.1 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.2 |
GO:0071801 |
podosome assembly(GO:0071800) regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.1 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
| 0.1 |
0.2 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.3 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
0.1 |
GO:2000021 |
regulation of ion homeostasis(GO:2000021) |
| 0.1 |
0.3 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
2.4 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.1 |
1.5 |
GO:0045576 |
mast cell activation(GO:0045576) |
| 0.1 |
0.4 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
5.8 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.1 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.0 |
0.9 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.3 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.0 |
0.3 |
GO:0032472 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) manganese ion homeostasis(GO:0055071) |
| 0.0 |
1.5 |
GO:0060271 |
cilium morphogenesis(GO:0060271) |
| 0.0 |
0.4 |
GO:0006688 |
glycosphingolipid biosynthetic process(GO:0006688) |
| 0.0 |
0.3 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
| 0.0 |
0.4 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 0.0 |
1.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.0 |
0.2 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.0 |
0.4 |
GO:0070059 |
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.0 |
0.9 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.0 |
0.2 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 |
0.2 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.1 |
GO:0007548 |
sex differentiation(GO:0007548) |
| 0.0 |
0.1 |
GO:0042727 |
flavin-containing compound metabolic process(GO:0042726) flavin-containing compound biosynthetic process(GO:0042727) |
| 0.0 |
0.2 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
1.7 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.0 |
0.1 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.0 |
0.2 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.0 |
4.7 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.0 |
0.1 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.0 |
0.1 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.0 |
0.5 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.0 |
GO:0070244 |
negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.0 |
0.8 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
1.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.2 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.9 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
1.8 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.0 |
0.0 |
GO:0098762 |
meiotic cell cycle phase(GO:0098762) |
| 0.0 |
0.4 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
0.6 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
0.1 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.0 |
0.2 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.0 |
0.1 |
GO:0060674 |
placenta blood vessel development(GO:0060674) |
| 0.0 |
0.1 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.0 |
0.2 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.0 |
0.3 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.0 |
0.1 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.0 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.0 |
0.0 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.1 |
GO:0007435 |
salivary gland morphogenesis(GO:0007435) |
| 0.0 |
0.3 |
GO:0002062 |
chondrocyte differentiation(GO:0002062) |
| 0.0 |
0.1 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.0 |
0.1 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0051271 |
negative regulation of cellular component movement(GO:0051271) |
| 0.0 |
1.8 |
GO:0006986 |
response to unfolded protein(GO:0006986) |
| 0.0 |
0.4 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
0.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 |
1.3 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.0 |
0.2 |
GO:2001022 |
positive regulation of DNA repair(GO:0045739) positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.0 |
0.1 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.0 |
0.1 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.0 |
0.1 |
GO:0007285 |
primary spermatocyte growth(GO:0007285) |
| 0.0 |
0.2 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.0 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.1 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.0 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) positive regulation of ATP metabolic process(GO:1903580) |
| 0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.2 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 0.0 |
1.2 |
GO:0006665 |
sphingolipid metabolic process(GO:0006665) |
| 0.0 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.0 |
0.1 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.7 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.0 |
0.1 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.0 |
0.2 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.0 |
0.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 |
0.2 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.0 |
0.0 |
GO:0010982 |
regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.0 |
1.2 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.2 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.1 |
GO:0032754 |
positive regulation of interleukin-5 production(GO:0032754) |
| 0.0 |
0.3 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.3 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
| 0.0 |
0.2 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 0.0 |
0.8 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.0 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.0 |
0.6 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.2 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.0 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.0 |
0.1 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
| 0.0 |
0.0 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.0 |
0.0 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.0 |
0.3 |
GO:0015758 |
hexose transport(GO:0008645) monosaccharide transport(GO:0015749) glucose transport(GO:0015758) |
| 0.0 |
0.1 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.6 |
GO:0042157 |
lipoprotein metabolic process(GO:0042157) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.3 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.1 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.2 |
GO:0043392 |
negative regulation of DNA binding(GO:0043392) |
| 0.0 |
0.5 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.2 |
GO:0040014 |
regulation of multicellular organism growth(GO:0040014) |
| 0.0 |
0.5 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.1 |
GO:0042267 |
natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.0 |
0.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.8 |
GO:0045444 |
fat cell differentiation(GO:0045444) |
| 0.0 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.1 |
GO:0001974 |
blood vessel remodeling(GO:0001974) |
| 0.0 |
0.3 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.0 |
0.0 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.1 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.0 |
0.0 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.1 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.1 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
1.4 |
GO:0030029 |
actin filament-based process(GO:0030029) |
| 0.0 |
0.0 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.0 |
0.0 |
GO:0048483 |
autonomic nervous system development(GO:0048483) |
| 0.0 |
0.7 |
GO:0031589 |
cell-substrate adhesion(GO:0031589) |
| 0.0 |
0.1 |
GO:0045066 |
regulatory T cell differentiation(GO:0045066) |
| 0.0 |
0.1 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.0 |
0.1 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.0 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.0 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.0 |
0.2 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.1 |
GO:0000019 |
regulation of mitotic recombination(GO:0000019) |
| 0.0 |
0.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 |
0.0 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
2.5 |
GO:0006897 |
endocytosis(GO:0006897) |
| 0.0 |
0.2 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.1 |
GO:0006848 |
pyruvate transport(GO:0006848) |
| 0.0 |
0.0 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.0 |
GO:0044091 |
membrane biogenesis(GO:0044091) |
| 0.0 |
0.0 |
GO:0072332 |
intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
| 0.0 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.8 |
GO:0071559 |
response to transforming growth factor beta(GO:0071559) cellular response to transforming growth factor beta stimulus(GO:0071560) |
| 0.0 |
0.1 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.0 |
0.0 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.1 |
GO:0006906 |
vesicle fusion(GO:0006906) |
| 0.0 |
0.1 |
GO:0045927 |
positive regulation of growth(GO:0045927) |
| 0.0 |
0.1 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.0 |
0.0 |
GO:0034765 |
regulation of transmembrane transport(GO:0034762) regulation of ion transmembrane transport(GO:0034765) |
| 0.0 |
0.0 |
GO:0051057 |
positive regulation of small GTPase mediated signal transduction(GO:0051057) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0014909 |
smooth muscle cell migration(GO:0014909) |
| 0.0 |
0.5 |
GO:0007588 |
excretion(GO:0007588) |
| 0.0 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.0 |
0.0 |
GO:0051445 |
regulation of meiotic cell cycle(GO:0051445) |
| 0.0 |
0.0 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.1 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.0 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 0.0 |
0.2 |
GO:0006490 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
